Annual CFO
-$63.20 M
-$25.74 M-68.70%
31 December 2022
Summary:
Rain Therapeutics annual cash flow from operations is currently -$63.20 million, with the most recent change of -$25.74 million (-68.70%) on 31 December 2022. During the last 3 years, it has fallen by -$51.97 million (-462.72%).RAIN Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$7.00 M
+$16.63 M+70.37%
30 September 2023
Summary:
Rain Therapeutics quarterly cash flow from operations is currently -$7.00 million, with the most recent change of +$16.63 million (+70.37%) on 30 September 2023.RAIN Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$65.76 M
+$8.36 M+11.28%
30 September 2023
Summary:
Rain Therapeutics TTM cash flow from operations is currently -$65.76 million, with the most recent change of +$8.36 million (+11.28%) on 30 September 2023.RAIN TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RAIN Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -462.7% | +41.5% | -104.5% |
| 5 y5 years | - | - | - |
RAIN Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | +465.2% | +261.9% | +2540.8% |
Rain Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | -$7.00 M(-70.4%) | -$65.76 M(-11.3%) |
| June 2023 | - | -$23.62 M(+8.2%) | -$74.12 M(+9.1%) |
| Mar 2023 | - | -$21.84 M(+64.3%) | -$67.93 M(+7.5%) |
| Dec 2022 | -$63.20 M(+68.7%) | -$13.29 M(-13.5%) | -$63.20 M(+5.9%) |
| Sept 2022 | - | -$15.36 M(-11.9%) | -$59.66 M(+6.1%) |
| June 2022 | - | -$17.43 M(+1.9%) | -$56.26 M(+13.2%) |
| Mar 2022 | - | -$17.11 M(+75.3%) | -$49.71 M(+32.7%) |
| Dec 2021 | -$37.46 M | -$9.76 M(-18.4%) | -$37.46 M(+16.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | -$11.95 M(+9.8%) | -$32.16 M(+42.6%) |
| June 2021 | - | -$10.88 M(+123.7%) | -$22.56 M(+65.8%) |
| Mar 2021 | - | -$4.87 M(+9.2%) | -$13.61 M(+21.2%) |
| Dec 2020 | -$11.23 M(+0.4%) | -$4.46 M(+89.5%) | -$11.23 M(+65.8%) |
| Sept 2020 | - | -$2.35 M(+21.6%) | -$6.78 M(+53.1%) |
| June 2020 | - | -$1.93 M(-22.3%) | -$4.42 M(+77.7%) |
| Mar 2020 | - | -$2.49 M | -$2.49 M |
| Dec 2019 | -$11.18 M | - | - |
FAQ
- What is Rain Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Rain Therapeutics?
- What is Rain Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Rain Therapeutics?
- What is Rain Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Rain Therapeutics?
What is Rain Therapeutics annual cash flow from operations?
The current annual CFO of RAIN is -$63.20 M
What is the all time high annual CFO for Rain Therapeutics?
Rain Therapeutics all-time high annual cash flow from operations is -$11.18 M
What is Rain Therapeutics quarterly cash flow from operations?
The current quarterly CFO of RAIN is -$7.00 M
What is the all time high quarterly CFO for Rain Therapeutics?
Rain Therapeutics all-time high quarterly cash flow from operations is -$1.93 M
What is Rain Therapeutics TTM cash flow from operations?
The current TTM CFO of RAIN is -$65.76 M
What is the all time high TTM CFO for Rain Therapeutics?
Rain Therapeutics all-time high TTM cash flow from operations is -$2.49 M